|
MLXIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.744200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.052360E-01 |
| Normal-vs-Stage2 |
4.906400E-01 |
| Normal-vs-Stage3 |
9.409800E-01 |
| Normal-vs-Stage4 |
4.721800E-01 |
| Stage1-vs-Stage2 |
7.943600E-01 |
| Stage1-vs-Stage3 |
3.026600E-01 |
| Stage1-vs-Stage4 |
9.583000E-01 |
| Stage2-vs-Stage3 |
6.034200E-01 |
| Stage2-vs-Stage4 |
8.137600E-01 |
| Stage3-vs-Stage4 |
5.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.832760E-01 |
| Normal-vs-AfricanAmerican |
3.667400E-01 |
| Normal-vs-Asian |
1.981210E-03 |
| Caucasian-vs-AfricanAmerican |
9.053600E-01 |
| Caucasian-vs-Asian |
1.536810E-01 |
| AfricanAmerican-vs-Asian |
1.239390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.876300E-02 |
| Normal-vs-Female |
3.433000E-01 |
| Male-vs-Female |
1.654260E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.504000E-01 |
| Normal-vs-Extreme_Weight |
8.875500E-03 |
| Normal-vs-Obese |
4.329400E-01 |
| Normal-vs-Extreme_Obese |
6.188900E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.144600E-01 |
| Normal_Weight-vs-Obese |
1.646170E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.429600E-02 |
| Extreme_Weight-vs-Obese |
6.982800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.328800E-01 |
| Obese-vs-Extreme_Obese |
5.967300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.578600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.492400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.567940E-02 |
| Normal-vs-Age(81-100Yrs) |
1.530340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.320600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.547600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.670400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.543540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.575800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.882000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.624300E-02 |
| Normal-VS-Type2 PRCC |
4.209500E-02 |
| Normal-VS-KIRP CIMP |
2.530600E-01 |
| Normal-VS-Unclassified PRCC |
5.722400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.436600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.106400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.097060E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.465580E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.983000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
7.389400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.636800E-03 |
| Normal-vs-N1 |
8.831600E-01 |
| Normal-vs-N2 |
7.294000E-01 |
| N0-vs-N1 |
6.233700E-02 |
| N0-vs-N2 |
8.837900E-02 |
| N1-vs-N2 |
7.600800E-01 |
|
|
